Coldstream Capital Management Inc. Reduces Stock Position in Aflac Incorporated (NYSE:AFL)

Coldstream Capital Management Inc. lessened its holdings in Aflac Incorporated (NYSE:AFL) by 1.1% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 62,765 shares of the financial services provider’s stock after selling 693 shares during the quarter. Coldstream Capital Management Inc.’s holdings in Aflac were worth $5,606,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Eudaimonia Partners LLC increased its holdings in Aflac by 234.6% in the fourth quarter. Eudaimonia Partners LLC now owns 10,448 shares of the financial services provider’s stock valued at $862,000 after buying an additional 7,325 shares during the last quarter. Crossmark Global Holdings Inc. increased its holdings in Aflac by 22.6% in the fourth quarter. Crossmark Global Holdings Inc. now owns 86,010 shares of the financial services provider’s stock valued at $7,096,000 after buying an additional 15,855 shares during the last quarter. Southeast Asset Advisors Inc. increased its holdings in Aflac by 0.4% in the fourth quarter. Southeast Asset Advisors Inc. now owns 139,164 shares of the financial services provider’s stock valued at $11,481,000 after buying an additional 589 shares during the last quarter. Nordea Investment Management AB increased its holdings in Aflac by 6.7% in the first quarter. Nordea Investment Management AB now owns 1,806,475 shares of the financial services provider’s stock valued at $155,140,000 after buying an additional 113,226 shares during the last quarter. Finally, Richard C. Young & CO. LTD. purchased a new position in Aflac in the fourth quarter valued at $12,546,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Aflac Price Performance

Shares of AFL opened at $109.40 on Tuesday. Aflac Incorporated has a fifty-two week low of $74.89 and a fifty-two week high of $111.14. The company has a market capitalization of $61.27 billion, a price-to-earnings ratio of 12.07, a price-to-earnings-growth ratio of 2.57 and a beta of 0.95. The firm has a 50-day simple moving average of $99.53 and a 200-day simple moving average of $90.25. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.10 and a current ratio of 0.10.

Aflac (NYSE:AFL) last announced its earnings results on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.23. Aflac had a net margin of 28.35% and a return on equity of 16.22%. The business had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $4.10 billion. During the same quarter in the prior year, the firm earned $1.58 earnings per share. The business’s quarterly revenue was down .7% compared to the same quarter last year. On average, equities research analysts anticipate that Aflac Incorporated will post 6.75 earnings per share for the current year.

Aflac Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 2nd. Investors of record on Wednesday, August 21st were given a $0.50 dividend. The ex-dividend date was Wednesday, August 21st. This represents a $2.00 dividend on an annualized basis and a yield of 1.83%. Aflac’s payout ratio is currently 22.08%.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. JPMorgan Chase & Co. increased their target price on Aflac from $80.00 to $83.00 and gave the company a “neutral” rating in a report on Tuesday, July 2nd. Bank of America raised their price objective on Aflac from $108.00 to $115.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Citigroup raised their price objective on Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a report on Tuesday, July 23rd. Truist Financial raised their price objective on Aflac from $82.00 to $100.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, Morgan Stanley raised their price objective on Aflac from $91.00 to $98.00 and gave the stock an “equal weight” rating in a report on Monday, August 19th. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $92.50.

Insider Activity at Aflac

In related news, Director Thomas J. Kenny sold 2,000 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total value of $197,880.00. Following the completion of the sale, the director now owns 18,158 shares in the company, valued at $1,796,552.52. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.90% of the stock is owned by insiders.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.